TA

Healthcare · Medical Equipment & Supplies

Tarsons Products Ltd (TARSONS)

₹303.40

Mkt cap
₹1,614 Cr
P/E ratio
197.00
P/B
2.55
Div yield
0.00%
ROE
2.44%
ROCE
4.59%
EPS (TTM)
₹1.54
Book value
₹119
52W range
164–375
Sector
Healthcare

Price history

Previous close

Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals [1]

NSE TARSONSBSE 543399
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−19.09% from high
₹303
₹164+84.49% from low₹375
Current
₹303.40
Prev close
₹303.70
Day
−0.10%
Price performance
1D
−0.16%
1W
−3.88%
1M
−1.77%
3M
−10.11%
6M
+43.68%
1Y
+26.49%
YTD
+28.97%

Financials

Revenue, profit & margin
P/E ratio
197.0×
TARSONS is 434% above the sector median of 36.9×
TARSONS197.0×
Sector median36.9×
 Mar 2022Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales84.9461.79105.7284.8099.2595.68112.6991.36102.33107.89120.93110.24123.65
YoY Sales growth+25.73%+54.85%+6.59%+7.74%+3.10%+12.76%+7.31%+20.67%+20.83%
Expenses40.6138.9175.4866.0473.9466.0475.6766.6674.8876.3786.6684.2592.55
Operating Profit44.3322.8830.2418.7625.3129.6437.0224.7027.4531.5234.2725.9931.10
OPM %52.19%37.03%28.60%22.12%25.50%30.98%32.85%27.04%26.82%29.21%28.34%23.58%25.15%
Other Income2.583.243.382.918.430.853.783.345.807.076.835.984.43
Interest0.452.514.254.324.845.035.205.075.186.056.256.276.60
Depreciation7.2410.0612.3311.0314.0317.4120.0319.9422.4825.0429.0827.0228.26
Profit before tax39.2213.5517.046.3214.878.0515.573.035.597.505.77-1.320.67
Tax %24.89%26.72%39.50%36.39%30.80%34.66%34.49%41.25%40.61%32.93%27.56%9.09%150.75%
Net Profit29.469.9310.324.0210.295.2610.201.783.325.044.18-1.44-0.34
EPS in Rs5.541.871.940.761.930.991.920.330.620.950.79-0.27-0.06
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −1.98% · closed higher next day 0 of last 2
 Q1FY27Q2FY27
Broadcast10 Aug '26◦12 Nov '26
Earnings day−5.20%+1.24%
+1 day−0.22%−0.42%
+5 days+7.38%−2.70%
+15 days+9.76%—
+30 days+7.00%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
47.30%Promoter
Promoters47.30%
FIIs0.55%0.40
DIIs0.61%0.51
Public51.53%0.91
Ownership trend

Peers

7 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Molbio Diagnosti₹1,495.50237.6817,2340.00%8−86.23%259−55.36%18.48%
Poly Medicure₹1,635.7052.4616,5800.21%95−4.31%581+30.79%12.50%
Sahajanand Medi₹527.6074.685,3630.00%26+32.12%373+24.69%11.35%
Tarsons Products₹303.40197.341,6140.00%0−110.24%124+20.83%4.59%
Fischer Medical₹22.33137.101,5600.22%1−94.22%107+24.50%11.45%
Laxmi Dental₹187.5728.451,0320.00%10+17.58%80+10.03%15.05%
Q-Line Biotech₹396.8016.919260.00%20−8.07%152+5.83%22.45%
Median: 18 Co.₹302.9036.926640.00%5−6.19%83+17.91%15.05%

Filings